Bruze Lab Private Limited - pharma in Vasai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24296MH2014PTC251724 Incorporated 04 January 2014 ROC Mumbai HQ Vasai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2019
₹3.72 Lakh
▼ 91% YoY
Net loss · FY 2019
₹4.76 Lakh
Net margin -128%
EBITDA · FY 2019
-₹1.51 Lakh
EBITDA margin -40.7%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Satisfied charges
₹15 Lakh
No open charges
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings

About Bruze Lab Private Limited

Data last updated:

Bruze Lab Private Limited is a private limited company based in Vasai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 January 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24296MH2014PTC251724. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prabhudutt Surendranath Upadhyay and Ritesh Tejbahadur Singh.

Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Shop No 07 Ramrahim Manzil Chs Ltd Om Nagar Diwanman Dhuri Complex, Vasai, Maharashtra, India – 401202.

As per the financials filed for FY 2019, the company reported a revenue of ₹3.72 Lakh, a decline of 91% compared to the previous year. For the same year it recorded a net loss of ₹4.76 Lakh (net margin -128%) and EBITDA of -₹1.51 Lakh (EBITDA margin -40.7%). Revenue has declined at a compounded annual rate (CAGR) of 66% over three years.

As per MCA filings, the company has satisfied charges of ₹15 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U24296MH2014PTC251724
Registration Number 251724
Incorporation Date 04 January 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Non-Compliant

Contact details

Bruze Lab Private Limited's registered office is in Vasai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No 07 Ramrahim Manzil Chs Ltd Om Nagar Diwanman Dhuri Complex, Vasai, Maharashtra, India – 401202
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Bruze Lab Private Limited, buy the company report.

Comprehensive company report
Bruze Lab Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bruze Lab is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Bruze Lab Private Limited, buy the company report.

Financials of Bruze Lab Private Limited

FY 2019 filings available

Bruze Lab Private Limited reported revenue of ₹3.72 Lakh (down 91% YoY) for FY 2019.

Revenue · FY 2019
₹3.72 Lakh ▼ 91%
Net loss · FY 2019
₹4.76 Lakh margin -128%
EBITDA · FY 2019
-₹1.51 Lakh margin -40.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 91%
3 years · compounded
▼ 66%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▼ 42%

Revenue has declined at a compounded annual rate (CAGR) of 66% over three years, including a 91% fall in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹3.72 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.51 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹4.76 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-40.7%
Net Profit Margin-128%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bruze Lab Private Limited, buy the company report.

Board of directors of Bruze Lab Private Limited

Bruze Lab has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Prabhudutt Surendranath UpadhyayDirector15 Sep 20188 Years 1 MonthsCurrent
Ritesh Tejbahadur SinghDirector01 Feb 20179 Years 8 MonthsCurrent
Anshu RaiDirector04 Jan 201412 Years 9 MonthsCurrent

Auditor

Bruze Lab Private Limited is audited by SHAILESH SHARMA & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
SHAILESH SHARMA & COFY 2019136853W

Shareholding

The shareholding of Bruze Lab Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bruze Lab Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹15 Lakh
Breakdown by lending institutions
Others₹0.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Feb 2017100077804Others₹15 LakhSatisfied

To see the full charge records of Bruze Lab Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bruze Lab Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Bruze Lab has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Bruze Lab Private Limited, buy the company report.

Recent activity

Bruze Lab Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Sunita Rajkumar Soni ceased to be Director on 20 Apr 2022.

Ceased
Sunita Rajkumar Soni ceased to be Director.
Charges
A charge registered on 02 Feb 2017 via Charge ID 100077804 with Others was fully satisfied on 13 Apr 2022.
AGM
Bruze Lab Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Ceased
Prabhudutt Surendranath Upadhyay ceased to be Director.
Filing
Bruze Lab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai.
Appointed
Prabhudutt Surendranath Upadhyay was appointed as Director.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100077804 was registered on 02 Feb 2017.
Appointed
Ritesh Tejbahadur Singh was appointed as Director.
Ceased
Yogendra Prasad Sharma ceased to be Director.
Appointed
Anshu Rai was appointed as Director.
Incorporation
04 Jan 2014
Bruze Lab Private Limited was registered on 04 Jan 2014 with Roc Mumbai & aged 12 years 9 months as per MCA records.

Frequently asked questions

Bruze Lab is an active private limited company based in Vasai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 January 2014 (12+ years old) and is registered under CIN U24296MH2014PTC251724.

Bruze Lab has 3 current directors:

The latest financial statements of Bruze Lab on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.

No. Bruze Lab has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Bruze Lab is U24296MH2014PTC251724. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bruze Lab has 2 court cases on record: 2 filed against it.

Bruze Lab was incorporated on 04 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.

Sunita Rajkumar Soni ceased to be Director on 20 Apr 2022. Prabhudutt Surendranath Upadhyay ceased to be Director on 30 Apr 2019. Prabhudutt Surendranath Upadhyay was appointed as Director on 15 Sep 2018. Bruze Lab has 6 board changes on record in total.

The registered office of Bruze Lab is at Shop No 07 Ramrahim Manzil Chs Ltd Om Nagar Diwanman Dhuri Complex, Vasai, Maharashtra, India – 401202.

Bruze Lab operates in the pharma industry, in the drug formulation and development segment.